A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants With Severe Renal Impairment, End-stage Kidney Disease, and in Healthy Participants

NCT06693765 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Impairment
End-stage Kidney Disease
Healthy Participants

Interventions

DRUG: AZD4144

Sponsor

AstraZeneca

Collaborators

[object Object]